[Multiple sclerosis: immunomodulators brake the appearance of "black holes"].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001369:Axons; D002986:Clinical Trials as Topic; D000068717:Glatiramer Acetate; D006801:Humans; D008137:Longitudinal Studies; D015337:Multicenter Studies as Topic; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009836:Oligodendroglia; D010455:Peptides / Q000627:therapeutic use*; D010587:Phagocytosis; D013997:Time Factors
D000276:Adjuvants, Immunologic; D018696:Neuroprotective Agents; D010455:Peptides; D000068717:Glatiramer Acetate